Literature DB >> 32065834

Transdisciplinary Research in Energetics and Cancer early career investigator training program: first year results.

Melinda L Irwin1,2, Diana Lowry3, Marian L Neuhouser3, Jennifer Ligibel4, Kathryn Schmitz5, Ruth E Patterson6, Graham Colditz7, Fangyong Li1,2, Linda Nebeling8.   

Abstract

Energy imbalance increases cancer burden by increasing cancer risk and mortality. Training early career investigators on conducting impactful energy balance and cancer research is needed. We developed a Transdisciplinary Research in Energetics and Cancer (TREC) Training Program for early career investigators. This analysis examined program satisfaction, knowledge gained, publications, and awards among Year 1 participants (i.e., fellows). The program consists of an in-person course, followed by 1 year of mentorship. Faculty and fellows completed precourse and postcourse surveys. Following the mentorship period, we surveyed fellows for TREC-related research productivity, including publications and grant funding attributed to the program. Twenty fellows were accepted into the program: 3 basic, 7 clinical, and 10 population scientists. Sixteen fellows were junior faculty and four were postdoctoral fellows. The course included ~50 lectures, small group sessions, and faculty-fellow sessions. 96.7% of attendees rated the course in the highest categories of "good/very good." Knowledge significantly improved in 37 of 39 research competencies (94.8%). In the 18 months following the course, fellows published 25 manuscripts, with 3 published in journals with impact factor ≥10. Nineteen grants were funded to TREC fellows (i.e., 7 National Institutes of Health awards, 2 American Cancer Society [ACS] awards, and 10 foundation/pilot awards), and 7 fellows received career promotions. The program's impact will be defined by the degree to which TREC fellows produce discoveries that could improve the health of populations at risk for and/or surviving cancer. Upon the conclusion of our fifth year in 2021, we will publicly disseminate the program material. © Society of Behavioral Medicine 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cancer; Career development; Diet; Exercise; Mentoring; Mortality; Obesity; Physical activity; Recurrence; Survival; Weight

Year:  2021        PMID: 32065834      PMCID: PMC7963289          DOI: 10.1093/tbm/ibaa009

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  33 in total

1.  Hispanic ethnicity as a moderator of the effects of aerobic and resistance exercise in survivors of breast cancer.

Authors:  Christina M Dieli-Conwright; Frank C Sweeney; Kerry S Courneya; Debu Tripathy; Nathalie Sami; Kyuwan Lee; Thomas A Buchanan; Darcy Spicer; Leslie Bernstein; Joanne E Mortimer; Wendy Demark-Wahnefried
Journal:  Cancer       Date:  2018-11-30       Impact factor: 6.860

2.  Trends in Obesity Among Adults in the United States, 2005 to 2014.

Authors:  Katherine M Flegal; Deanna Kruszon-Moran; Margaret D Carroll; Cheryl D Fryar; Cynthia L Ogden
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

3.  Wearable Technology and Physical Activity in Chronic Disease: Opportunities and Challenges.

Authors:  Siobhan M Phillips; Lisa Cadmus-Bertram; Dori Rosenberg; Matthew P Buman; Brigid M Lynch
Journal:  Am J Prev Med       Date:  2017-11-06       Impact factor: 5.043

4.  Evaluation of the Physical Activity and Public Health Course for Researchers.

Authors:  Kelly R Evenson; Joan M Dorn; Ricky Camplain; Russell R Pate; David R Brown
Journal:  J Phys Act Health       Date:  2014-10-01

5.  The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes.

Authors:  Ruth E Patterson; Catherine R Marinac; Dorothy D Sears; Jacqueline Kerr; Sheri J Hartman; Lisa Cadmus-Bertram; Adriana Villaseñor; Shirley W Flatt; Suneeta Godbole; Hongying Li; Gail A Laughlin; Jesica Oratowski-Coleman; Barbara A Parker; Loki Natarajan
Journal:  J Natl Cancer Inst       Date:  2018-11-01       Impact factor: 13.506

6.  Variation in actigraphy-estimated rest-activity patterns by demographic factors.

Authors:  Jonathan A Mitchell; Mirja Quante; Suneeta Godbole; Peter James; J Aaron Hipp; Catherine R Marinac; Sara Mariani; Elizabeth M Cespedes Feliciano; Karen Glanz; Francine Laden; Rui Wang; Jia Weng; Susan Redline; Jacqueline Kerr
Journal:  Chronobiol Int       Date:  2017-06-26       Impact factor: 2.877

7.  Stratified Probabilistic Bias Analysis for Body Mass Index-related Exposure Misclassification in Postmenopausal Women.

Authors:  Hailey R Banack; Andrew Stokes; Matthew P Fox; Kathleen M Hovey; Elizabeth M Cespedes Feliciano; Erin S LeBlanc; Chloe Bird; Bette J Caan; Candyce H Kroenke; Matthew A Allison; Scott B Going; Linda Snetselaar; Ting-Yuan David Cheng; Rowan T Chlebowski; Marcia L Stefanick; Michael J LaMonte; Jean Wactawski-Wende
Journal:  Epidemiology       Date:  2018-09       Impact factor: 4.822

8.  Zeitgebers and their association with rest-activity patterns.

Authors:  Mirja Quante; Sara Mariani; Jia Weng; Catherine R Marinac; Emily R Kaplan; Michael Rueschman; Jonathan A Mitchell; Peter James; J Aaron Hipp; Elizabeth M Cespedes Feliciano; Rui Wang; Susan Redline
Journal:  Chronobiol Int       Date:  2018-10-26       Impact factor: 2.877

9.  Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: a prospective analysis in three large cohorts.

Authors:  Catherine R Marinac; Brenda M Birmann; I-Min Lee; Bernard A Rosner; Mary K Townsend; Edward Giovannucci; Timothy R Rebbeck; Julie E Buring; Graham A Colditz
Journal:  Br J Cancer       Date:  2018-03-12       Impact factor: 7.640

10.  The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth.

Authors:  Laura W Bowers; Claire G Lineberger; Nikki A Ford; Emily L Rossi; Arunima Punjala; Kristina K Camp; Bruce K Kimler; Carol J Fabian; Stephen D Hursting
Journal:  Breast Cancer Res Treat       Date:  2018-10-26       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.